Subarachnoid or Infiltration for Hemorrhoidectomy
Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy
1 other identifier
interventional
40
1 country
1
Brief Summary
There will be compared the postoperative analgesic effect of infiltration or spinal block for hemorrhoidectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedFirst Posted
Study publicly available on registry
August 23, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedFebruary 3, 2016
February 1, 2016
2.8 years
August 23, 2012
February 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity
Numerical score
24 hours
Secondary Outcomes (1)
Time to discharge
24 hours
Other Outcomes (1)
Duration of motor blockade
24 hours
Study Arms (2)
Infiltration, analgesic effect
ACTIVE COMPARATOR10ml 0.5% bupivacaine each side Block Injection of local anesthetic at pudendal nerve
Spinal block
ACTIVE COMPARATOR10 mg of hyperbaric 0.5% bupivacaine Injection of anesthetic at subarachnoidal space
Interventions
injection of local anesthetic, associated with general anesthesia
10ml 0.5% bupivacaine.
Spinal punction and injection of local anesthetic
Eligibility Criteria
You may qualify if:
- Will be included 50 patients, ASA physical status 1 or 2 undergoing hemorrhoidectomy after approval by the Ethics Committee and signed Consent Form
You may not qualify if:
- There will be excluded patients with associated diseases (fistula, fissure), infection at the puncture site, using anticoagulants or analgesics (up to 2 weeks before the procedure) and pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal de São Paulo
São Paulo, São Paulo, 04044020, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rioko K Sakata, PhD
Universidade Federal de São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 23, 2012
First Posted
August 23, 2013
Study Start
January 1, 2013
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
February 3, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share